Published in Anticancer Res on July 27, 2004
Chondromyxoid fibroma of rib with a novel chromosomal translocation: a report of four additional cases at unusual sites. Diagn Pathol (2007) 0.99
Unusual association between enchondroma and Camurati-Engelmann disease: a case report. Ups J Med Sci (2010) 0.75
De novo 13q13.3-21.31 deletion involving RB1 gene in a patient with hemangioendothelioma of the liver. Ital J Pediatr (2014) 0.75
Molecular pathology of chondroid neoplasms: part 2, malignant lesions. Skeletal Radiol (2006) 0.75
Molecular pathology of chondroid neoplasms: part 1, benign lesions. Skeletal Radiol (2006) 0.75
Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol (2002) 10.03
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell (2002) 5.58
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol (2003) 3.93
Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care (2004) 3.87
Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology (2004) 2.41
Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest (2002) 2.33
Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res (2006) 2.13
Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation. Am J Gastroenterol (2004) 1.96
Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology (2005) 1.79
Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol (2003) 1.78
Activation of Akt predicts poor outcome in neuroblastoma. Cancer Res (2007) 1.76
Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys (2003) 1.70
Silver-coated megaendoprostheses in a rabbit model--an analysis of the infection rate and toxicological side effects. Biomaterials (2004) 1.69
Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials (2007) 1.66
Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J Clin Oncol (2010) 1.65
Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J Pathol (2002) 1.59
Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol (2002) 1.56
RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods. Clin Chem (2009) 1.56
Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis. Breast Cancer Res Treat (2005) 1.52
Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort. Genes Chromosomes Cancer (2010) 1.50
Osteoid osteoma and osteoblastoma of the spine: experiences with 22 patients. Clin Orthop Relat Res (2002) 1.42
EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma. Cancer Res (2008) 1.38
Injuries and overuse syndromes in golf. Am J Sports Med (2003) 1.38
BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis (2004) 1.34
En bloc spondylectomy in malignant tumors of the spine. Eur Spine J (2008) 1.27
Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One (2013) 1.27
Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma. Clin Cancer Res (2010) 1.25
Relationship between MYCN copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype. J Clin Oncol (2005) 1.25
Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group. Cancer (2002) 1.25
Grade I chondrosarcoma of bone: the Münster experience. J Cancer Res Clin Oncol (2008) 1.25
Treatment options for recurrent giant cell tumors of bone. J Cancer Res Clin Oncol (2008) 1.24
Rotationplasty--quality of life after 10 years in 22 patients. Acta Orthop Scand (2002) 1.21
Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis. J Cancer Res Clin Oncol (2003) 1.20
Primitive neuroectodermal tumor (PNET) in the differential diagnosis of malignant kidney tumors. Pathol Res Pract (2002) 1.20
EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin. Oncogene (2005) 1.19
Osteosarcoma: the COSS experience. Cancer Treat Res (2009) 1.18
Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur J Cancer (2008) 1.18
Implantation of hemipelvic prosthesis after resection of sarcoma. Clin Orthop Relat Res (2002) 1.15
Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up. Clin Cancer Res (2003) 1.14
Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays. Int J Oncol (2002) 1.13
Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. Clin Cancer Res (2004) 1.13
Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer. Int J Cancer (2006) 1.11
Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma. J Invest Dermatol (2004) 1.11
A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study. Cancer Res (2008) 1.09
Long-term survival after surgery for primary hepatic sarcoma in adults. Arch Surg (2009) 1.08
Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy. Int J Cancer (2006) 1.07
Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity. Int J Cancer (2008) 1.07
Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas. Mol Cancer Ther (2009) 1.05
Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro. Cancer Res (2010) 1.05
Human endomucin: distribution pattern, expression on high endothelial venules, and decoration with the MECA-79 epitope. Am J Pathol (2002) 1.04
Giant cell tumor of the spine. Clin Orthop Relat Res (2002) 1.03
Hip transposition as a limb salvage procedure following the resection of periacetabular tumors. J Surg Oncol (2010) 1.03
Factors influencing the agreement on histopathological assessments of breast biopsies among pathologists. Histopathology (2011) 1.01
Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry. Hum Pathol (2003) 1.00
Absence of pathognomonic or inflammatory patterns in cardiac biopsies from patients with Brugada syndrome. Circ Arrhythm Electrophysiol (2008) 0.99
Primary stability in cementless femoral stems: custom-made versus conventional femoral prosthesis. Clin Biomech (Bristol, Avon) (2002) 0.99
Constitutive activation of neuregulin/ERBB3 signaling pathway in clear cell sarcoma of soft tissue. Neoplasia (2006) 0.98
Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3. Cancer Res (2004) 0.98
Profiling and functional annotation of mRNA gene expression in pediatric rhabdomyosarcoma and Ewing's sarcoma. Int J Cancer (2004) 0.98
Radiotherapy in Ewing tumors of the vertebrae: treatment results and local relapse analysis of the CESS 81/86 and EICESS 92 trials. Int J Radiat Oncol Biol Phys (2005) 0.96
Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas. Int J Cancer (2002) 0.96
Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: a report from the cooperative soft tissue sarcoma study group (CWS). Pediatr Blood Cancer (2011) 0.94
Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy. Clin Cancer Res (2007) 0.94
FOXM1 is an oncogenic mediator in Ewing Sarcoma. PLoS One (2013) 0.94
Recipient-derived hepatocytes in liver transplants: a rare event in sex-mismatched transplants. Hepatology (2002) 0.93
Ewing's sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-alpha (TNF-alpha) after radiation exposure. Int J Radiat Oncol Biol Phys (2003) 0.93
Estrogen receptor alpha and beta, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breast. Oncol Rep (2004) 0.92
Ewing's sarcoma and primitive neuroectodermal tumor of hand and forearm. Experience of the Cooperative Ewing's Sarcoma Study Group. J Cancer Res Clin Oncol (2004) 0.92
Mammographic density and inter-observer variability of pathologic evaluation of core biopsies among women with mammographic abnormalities. BMC Cancer (2012) 0.92
Peripheral primitive neuroectodermal tumor of the stomach in a 14-year-old boy: a case report. Eur J Gastroenterol Hepatol (2004) 0.91
Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples. Cancer (2006) 0.91
Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome. Clin Cancer Res (2007) 0.91
Hip transposition as a universal surgical procedure for periacetabular tumors of the pelvis. J Surg Oncol (2009) 0.90
Association of telomerase activity with radio- and chemosensitivity of neuroblastomas. Radiat Oncol (2010) 0.90
Pitfalls in the detection of t(11;22) translocation by fluorescence in situ hybridization and RT-PCR: a single-blinded study. Diagn Mol Pathol (2006) 0.90
Leiomyosarcoma of the inferior vena cava: radical surgery and vascular reconstruction. World J Surg Oncol (2009) 0.89
Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma. Genes Chromosomes Cancer (2006) 0.89
Selective and nonselective toxicity of TRAIL/Apo2L combined with chemotherapy in human bone tumour cells vs. normal human cells. Int J Cancer (2003) 0.89
Loss of caspase-8 expression does not correlate with MYCN amplification, aggressive disease, or prognosis in neuroblastoma. Cancer Res (2006) 0.89
Gene therapy of beta(c)-deficient pulmonary alveolar proteinosis (beta(c)-PAP): studies in a murine in vivo model. Mol Ther (2008) 0.88
Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy. J Clin Oncol (2009) 0.88
Chromosomal imbalances in malignant peripheral nerve sheath tumor detected by metaphase and microarray comparative genomic hybridization. Oncol Rep (2006) 0.88